Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
Caribou Biosciences, Inc. (CRBU)
|
|
Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Gross profit | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Research and development | 705.8% | 734.1% | 697.1% | 605.2% | 538.6% | 522.7% | 590.5% | 398.1% |
General and administrative | 269.5% | 254.4% | 231.1% | 298.2% | 239.6% | 360.1% | 306.9% | 170.0% |
EBITDA | -858.9% | -871.7% | -814.5% | -803.4% | -669.7% | -771.2% | -786.7% | -461.6% |
Depreciation | 16.4% | 16.8% | 13.7% | | 8.5% | 11.6% | 10.7% | 6.5% |
EBIT | -875.3% | -888.5% | -828.2% | -803.4% | -678.2% | -782.8% | -797.4% | -468.1% |
Pre-tax income | -786.1% | -800.8% | -729.1% | -806.8% | -636.9% | -716.5% | -709.6% | -527.4% |
Income taxes | 0.0% | 0.0% | 1.9% | 0.0% | 0.0% | 0.0% | 12.5% | 0.0% |
Net income | -786.1% | -800.8% | -731.0% | -806.8% | -636.9% | -716.5% | -722.1% | -527.4% |
|